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PURPOSE. To investigate the developmental and ocular expres-
sion of Opa3 in a mouse model of 3-methylglutaconicaciduria
type III and the effect of mutation on protein localization and
mitochondrial morphology.
METHODS. The B6 C3-Opa3L122P mouse carrying a missense mu-
tation in exon 2 (c.365TC; p.L122P) of Opa3, which displays
features of recessive 3-methylglutaconic aciduria type III was
studied. The expression of Opa3 was determined with RT-PCR,
quantitative PCR, and Western blot, in embryos (embryonic
day [E]8 to postnatal day [P]0) and adult tissues, and by ocular
immunohistochemistry. Mitochondria were stained using a mi-
tochondrion-selective probe in mouse embryonic fibroblasts
from Opa3/ mutants and imaged by electron microscopy of
the retinas.
RESULTS. The splice variants Opa3a and Opa3b were ex-
pressed in the lenses and the retinas in the Opa3/ mice,
with the expression of the Opa3a isoform predominant.
Opa3 was expressed throughout embryonic development,
with high levels of expression in the developing brain,
retina, optic nerve, and lens. Opa3 localized to the mito-
chondria, and the L122P mutant protein did not mislocalize.
Neither protein localized to the peroxisome. Opa3/ mice
displayed disrupted mitochondrial morphology in the retina.
Wild-type Opa3 protein increased as the lenses aged, despite
the reduction in Opa3 mRNA occurring as a part of lens
differentiation. However, mutant Opa3 mRNA was upregu-
lated in homozygous mutant lenses, suggesting a compensa-
tory increase in expression, which may further increase
Opa3 protein levels.
CONCLUSIONS. Mutant Opa3 protein retains its mitochondrial
localization and induces disrupted mitochondrial morphology.
Opa3 accumulates in the lens. The results may reflect a slow
turnover of Opa3 protein in vivo and may be important in
normal lens physiology. (Invest Ophthalmol Vis Sci. 2011;52:
4369–4380) DOI:10.1167/iovs.10-6406
Hereditary optic neuropathies are a group of heteroge-neous disorders in which degeneration of the retinal
ganglion cells and optic nerve atrophy are the primary
characteristics. Autosomal dominant optic atrophy (ADOA;
MIM [Mendelian Inheritance in Man] 165500) is the most
common of these disorders and is frequently associated with
mutation of the OPA1 gene.1,2 However, optic atrophy has also
been linked to mutation in an unrelated nuclear gene, OPA3.
OPA3 is associated with two phenotypically distinct condi-
tions. ADOA and cataract are characterized by optic atrophy,
extrapyramidal signs, and blue-dot cerulean cataract (ADOAC,
MIM 1653003,4). Two dominant missense mutations that give
rise to this disorder have been reported4,5: a heterozygous
277G-A transition (c.277GA; p.G93S) and a 313C-G transver-
sion (c.313CG; p.Q105E), both in exon 2. Homozygous mu-
tations in the OPA3 gene have also been reported and are
responsible for recessive 3-methylglutaconic aciduria type III
or Costeff optic atrophy syndrome (3-MGCA: MIM 2585016).
Costeff syndrome is a neuro-ophthalmic syndrome character-
ized by increased urinary excretion of 3-methylglutaconic acid
and 3-methylglutaric acid, with early-onset bilateral optic atro-
phy, reduced visual acuity, and later-onset spasticity, extrapy-
ramidal dysfunction, and occasional cognitive defect.7 Three ho-
mozygous mutations have been reported in OPA3. The first
mutation to be reported was homozygous in all patients of Iraqi-
Jewish origin and is a splice site founder mutation, c.143–1GC
(IVS1-GC) that abolishes mRNA in fibroblasts.6 An in-frame
18-bp deletion in exon 2, c.320_337del (p.Q108_E113del),8 and a
homozygous nonsense mutation, c.415CT (p.Q139X), also in
exon 2,9 have also been reported.
Databases show that OPA3 consists of a 5 UTR, an open
reading frame encoding 179 amino acids, and 970 nucleo-
tides of 3 UTR sequence spanning approximately 57 kb on
human chromosome 19, region q13.2-q13.6 Recent evidence
shows that there are two alternate transcripts, OPA3A and
OPA3B,10 arising from alternate splicing of a third exon. OPA3
is a novel protein with no known homolog, and therefore no
useful predictions of tertiary structure can be made from bioin-
formatics databases. It is predicted to be a 20-kDa peptide
containing a mitochondrial leader and targeting sequence
(NRIKE) at amino acid residues 25-29 of the N terminus (http://
psort.nibb.ac.jp/ a collaborative database of Predictions of Pro-
tein Sorting Signals and Localization Sites in Amino Acid Se-
quences) and a putative peroxisomal sorting tripeptide signal
at the C-terminal.11 Green fluorescent protein–tagged OPA3
expression studies have found it to be localized predominantly
to mitochondria.10 Proteomic studies have shown that the
OPA3 gene encodes a mitochondria-related protein that may
localize to the inner mitochondrial membrane.12 However,
subcellular fractionation of cultured cell lines suggests rather
that OPA3 localizes to the outer mitochondrial membrane
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FIGURE 1.
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(MOM),13 with a C terminus exposed to the cytosol and an
N-terminal mitochondrial targeting domain.
Fibroblasts obtained from patients with ADOAC have been
shown to be particularly susceptible to apoptotic stimuli, al-
though, no abnormalities in the respiratory chain, mitochon-
drial membrane potential, or morphology of the mitochondrial
network were identified in these fibroblasts.4 However, Chevrol-
lier et al.,14 in studies of fibroblast cell lines, found reduced
membrane potential and a possible coupling defect in OXPHOS.
Overexpression of the G93S human OPA3 mutation in HeLa cells
increased cell death and mitochondrial fragmentation in the
absence of apoptotic stimuli.13 A model of 3-methylglutaconi-
caciduria type III (3-MGA) recently reported in Opa3 null allele
zebrafish,15 demonstrates normal mitochondrial oxidative
phosphorylation, but increased sensitivity to inhibitors of the
electron transport chain.
We have reported a mutant mouse (B6;C3-Opa3L122P) that
carries a missense point mutation in exon 2 (c.365TC;
p.L122P).16 Homozygous mice display a condition with many
similarities to the recessive 3-MGA type III disorder observed in
patients: impaired visual function consistent with loss of retinal
ganglion cells and degeneration of the optic nerve, elevated
serum organic acids, dilated cardiomyopathy, extrapyramidal
dysfunction, and gross neuromuscular defects. Here, we report
the expression of murine Opa3 splice variant transcripts and
Opa3 protein in development and maturation in a range of
tissues—most significantly, lens and retina in homozygous
mice carrying the p.L122P mutation. We studied mouse em-
bryonic fibroblasts deriving from these animals and localized
Opa3 to the mitochondria. We used electron microscopy to
assess mitochondrial morphology in retinal tissues from Opa3
mutant mice.
MATERIALS AND METHODS
Splice Variant Analysis
For RT-PCR to detect alternately spliced Opa3 isoforms in tissues, total
RNA was isolated from mouse eye, brain, liver, heart, skeletal muscle,
and kidney of adult wild-type mice (RNeasy Mini kit; Qiagen, Crawley,
UK). cDNA was synthesized (Quantitect Reverse Transcription Kit;
Qiagen), and RT-PCR was performed with primers in the Opa3 exon
coding regions spanning introns, close to exon–intron boundaries. The
primer sequences were F1: 5-GGCGAAGCTGTTCTACTTGG-3 (exon
1); R2: 5-TTATTGCGCTGCTGAGTCTG-3 (exon 2); and R3: 5-GCG-
GTGTTTCGATGACTTCT’ (exon 3) (Fig. 1A). (No-reverse-transcription
enzyme, genomic DNA, and water-only reactions were performed as
controls.) Transcripts 1-2 and transcripts 1-3 were sequenced (primers
available on request). PCR products were purified for sequencing
(QuickClean; BioLine, San Francisco, CA). All PCR products were
sequenced in forward and reverse to confirm the sequence. Mouse
exon alignments were performed by Clustal W.17
Quantitative RT-PCR
Three different samples of both lens and retina at both P7 and P30 from
three wild-type and three homozygous mutant Opa3 mice were har-
vested and placed in RNA stabilizer (RNAlater; Ambion, Austin, TX).
Total RNA was isolated (Trizol Reagent; Invitrogen, Carlsbad, CA) and
purified (RNeasy Clean Up kit; Qiagen). One microgram of total RNA
from each sample was reverse transcribed (High Capacity cDNA re-
verse transcription kit; Applied Biosystems, Inc. [ABI], Foster City, CA).
Quantitative PCR reactions were prepared (TaqMan Universal PCR
Master Mix, No AmpErase UNG; ABI) and mixed with cDNA, primers
and the probe gene-specific assay mix. Gene expression assays
(TaqMan; ABI) were used for Mus musculus Opa3 (assay ID:
Mm01702385_ml; (90-bp amplicon) and Mus musculus Sod2 super-
oxide dismutase 2 (assay ID: Mm00449726_ml; 67-bp amplicon; both
from ABI). The primer sequences for Opa3 are made on the exon–
exon junction (Assay ID: Mm01702385_ml) and detect both tran-
scripts. Primers for exon 1_3 transcript were designed in-house as F1
qPCR: 5-CCAGCCCAGCTGTACCA-3 and R3 qPCR: 5-TTGATGGCCT-
CAGCATGGAA-3 (which is specific for transcript b; Fig. 1A). qPCR was
performed in triplicate (7900HT Prism; ABI), with the mean CT values
used to calculate the relative gene expression levels after normalizing
to 18S RNA levels (endogenous control: VIC/MGB probe; Primer Lim-
ited; ABI). Analyses of relative gene expression data were performed
using the 2-CT method.
18 Statistical analysis was performed with the
Tukey post hoc test and expressed as ANOVA P values.
Tissue and Developmental Expression
Total RNA was isolated from whole wild-type mouse embryos at em-
bryonic day (E)8 and E10 and from body or head homogenates at E13,
E15, E17 and postnatal day (P)0 (RNeasy Mini kit; Qiagen). Retina, lens,
and optic nerve were dissected from adult wild-type eyes (P30). First-
strand cDNA synthesis was performed with kit (BioLine) with Oligo
(dT)18 primers. PCR was performed using mOpa3 primers that do not
distinguish between transcript a and transcript b, designed to span an
intron–exon boundary (forward 5-GGCGAAGCTGTTCTACTTGG-3;
reverse 5-CTGCTGCCTCCTCATTCAGT-3) giving a final product of
202 bp.
Isolation and Culture of Mouse Embryonic
Fibroblasts and Cell Lines
Embryos from Opa3, with or without crosses of G4 mice at E12.5, were
used to make wild-type and Opa3/ mouse embryonic fibroblast cell
lines. (All experimental work with animals used in this research ad-
hered to the ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research). Genotyping for Opa3 was performed according to
published protocols.16 The fibroblastic cell mass was dissociated with
a combination of trypsin and mechanical disruption. Cell slurries were
cultured in Dulbecco’s complete medium with high glucose (Invitro-
gen) supplemented with 10% heat-treated fetal calf serum, 2 mM
glutamine, and 100 g/mL primocin (Invitrogen). Vero, RGC-5, and Brl
cell lines were cultured in Dulbecco’s complete medium (Invitrogen)
supplemented with 10% fetal calf serum, 2 mM glutamine, 100 U/mL
penicillin, and 100 g/mL streptomycin.
Antibodies
Three different commercially available antibodies to OPA3 were used
in this study. A mouse polyclonal raised against full-length human
OPA3 (H00080207-B01P; Abnova-Novus Biologicals, Cambridge, UK),
a rabbit polyclonal raised against human OPA3 24-179 (15,638-1-AP ;
ProteinTech Group, Chicago, IL), and a goat polyclonal raised against
Š
FIGURE 1. Opa3 has two splice variants in mice, which are ubiquitously expressed. (A) Comparison of murine Opa3a (exon1-2) and Opa3b
(exon1-3) transcripts. Transcripts show an 81% sequence identity. Blue: exon 1; black: alternative second exons; red: first stop codon in each
transcript. Alignment was generated by the ClustalW2 program. (*) The residues or nucleotides in that column are identical in all sequences in the
alignment. F1, R2, and R3 show position of primers for identification of splice variants. (B) RT-PCR showing tissue expression of alternately splice
variants of murine Opa3 in a panel of tissues (eye, brain, liver, heart, skeletal muscle, and kidney). Gene: the Opa3 gene, showing the location of
RT-PCR primers used to verify third exon and splice variant. cDNA: exon 1 splices to exon 2, giving a product of 310 bp (12), or to exon3 giving
a product of 307 bp (13). Primers F1 and R3 did not give rise to a transcript product of Exons 123, suggesting that they are not spliced. (C,
D) qPCR showing relative expression of Opa3 transcripts a and b versus transcript a in lenses and retina from wild-type (/) or homozygous
mutant (/) animals at P7 and P30. *P  0.001.
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an internal epitope of human OPA3 (E15, sc-82004; Santa Cruz Bio-
technology, Santa Cruz, CA).
Other antibodies used were: PMP70, raised in rabbit (an3421;
Abcam, Cambridge UK), COX IV (HRP conjugate), mouse monoclonal
(ab62164; Abcam), -actin mouse monoclonal, clone AC-15 (AV5441;
Sigma-Aldrich, Poole, UK), MnSOD raised in rabbit (ab13533; Abcam),
and Porin rabbit polyclonal (Ab-5; Merck, Darmstadt, Germany).
Mitochondrial Visualization, Immunofluorescence
Staining, and Microscopy
Mitochondria were visualized by staining in live cells with the fixable
fluorescent red probe (MitoTracker Red CMXRos; Invitrogen, Paisley,
UK). The cells were seeded at the appropriate density onto poly-D-
lysine-coated glass coverslips and allowed to recover for 24 hours
before visualization by incubation with the red probe at a final con-
centration of 100 nM added to the culture medium for approximately
15 minutes. Cells, with or with the probe, were fixed and permeabil-
ized in cold methanol (20°C) for 10 minutes. Washes were per-
formed with PBS containing 0.05% saponin. Nonspecific sites were
blocked with 5% normal goat serum in PBS containing saponin (PBS/S)
for 1 hour at room temperature. Incubation with primary antibody
diluted in PBS/S containing 1% normal goat serum was performed
overnight at 4°C and visualized using fluorescent secondary antibodies
(AlexaFlour 488 or 594 F(ab)2 fragments of IgG (HL; Invitrogen)
diluted in PBS/S for 1 hour at room temperature. In some preparations,
nuclei were counterstained with aqueous Hoechst 33342 (1 g/mL).
Coverslips were mounted using an aqueous antifade mounting medium
(Fluosave; Calbiochem, San Diego, CA). Immunostaining of Opa3 was
performed using either the MaxPab mouse polyclonal antibody (Abnova)
or rabbit polyclonal antibody (ProteinTech Group). Peroxisomes were
labeled with an antibody to PMP-70. The images were acquired with a
fluorescence microscope (DM6000; Leica, Wetzlar, Germany) equipped
with a 63/1.4 oil differential interference contrast [DIC] objective (Plan
Apochromat; Carl Zeiss Meditec, Oberkochen , Germany).
Western Blot Analysis
Cell or tissue lysates were prepared by homogenization in RIPA buffer
containing a protease inhibitor cocktail (Sigma-Aldrich) on ice, fol-
lowed by brief centrifugation to remove debris. Reducing SDS-PAGE
was run routinely with Laemmli sample buffer containing a final con-
centration of 100 mM DTT up to a maximum concentration of 400 mM.
Subcellular fractionation was performed on cultures of mouse embry-
onic fibroblasts derived from wild-type or homozygous embryos. A
total of 2  107 cells per sample were lysed and separated into
fractions with a mitochondrial isolation kit (Qproteome; Qiagen). Sam-
ples were collected from each stage of the process (cytosol, micro-
some, and mitochondrial) and desalted and concentrated by acetone
precipitation, and protein concentration was determined. Equal
amounts of protein (50 g per lane) were loaded for each sample.
SDS-polyacrylamide electrophoresis was performed on 12% polyacryl-
amide gels (37.5 acrylamide:1 bis-acrylamide; Applichem; Merck) and
the separated proteins transferred to nitrocellulose membrane (0.2 m
pore size; Bio-Rad, Hemel Hempstead, UK). A variety of primary anti-
bodies were used to probe blots: OPA3 MaxPab mouse polyclonal
antibody (Abnova), OPA3 rabbit polyclonal (ProteinTech Group),
OPA3 goat polyclonal (not shown), MnSOD rabbit polyclonal, Porin/
VDAC rabbit polyclonal, COX IV horseradish peroxidase (HRP)-conju-
gated mouse polyclonal, and PMP-70 rabbit polyclonal. Detection was
by ECL using HRP-conjugated goat anti-mouse or goat anti-rabbit IgG
(HL) secondary antibodies (AffiniPure F(ab)2 Fragment; Jackson Im-
munoResearch Europe, Ltd., Newmarket, UK), and ECL substrate (Su-
perSignal West Pico; Thermo Scientific-Pierce, Rockford, IL) exposed
to clear blue x-ray film (CL-Xposure; Thermo Scientific).
Histology and DAB Immunohistochemistry
Eyes were removed whole, and the capsule was carefully scored with
a razor blade to enable penetration of the reagents. The tissue was
fixed in fresh 4% PFA in PBS, dehydrated through a prolonged series of
alcohols, and embedded in paraffin wax. Sections were mounted on
coated slides (Histobond; R.A. Lamb, Ltd., East Sussex, UK). Antigen
retrieval was performed by heating the slides in 10 mM sodium citrate
buffer (pH 6.0) for 10 minutes and/or digestion with 0.1% -chymo-
trypsin (Sigma-Aldrich). Nonspecific binding sites were blocked with
5% normal goat serum, 1% fatty acid-free fraction V BSA, 0.1% fish skin
gelatin, and 0.1% triton X-100 in PBS for 1 to 2 hours at room temper-
ature. Anti-OPA3 primary antibody (ProteinTech Group) was diluted in
PBS containing 1% normal goat serum and incubated overnight at 4°C.
Washes were performed with PBS containing 0.05% Tween 20 (PBS/T).
Sections were incubated with biotinylated secondary antibody (Strat-
ech, Newmarket, UK) diluted in PBS/T for 1 hour at room temperature,
followed by antifade reagent (RTU Vectastain ABC reagent, PK-7100;
Vector Laboratories, Peterborough, UK) for 30 minutes at room tem-
perature and then DAB substrate (DAB substrate kit for peroxidase;
Vector Laboratories). The sections were counterstained with Harris
hematoxylin (Thermo Scientific) and the images acquired (DMRA2
microscope with QWin software; Leica).
Electron Microscopy
Opa3/ mice and wild-type littermate controls were perfusion fixed
with a mixture of 4% paraformaldehyde and 5% glutaraldehyde in 0.1
M sodium cacodylate buffer at weaning (age 22 days). The eyes were
dissected, and small pieces of retina were removed and postfixed with
1% osmium tetroxide. The sections were poststained with uranyl
acetate and lead citrate, and representative micrographs were taken
across the retina at 5000 magnification.
Bioinformatics
To identify evolutionarily conserved regions (ECRs), the 5 untrans-
lated region of Opa3 was compared in a range of species by using
Mulan software19 (http://mulan.dcode.org/ sequence-alignment soft-
ware developed by a collaborative group). A region of 100 bp and
70% identity cutoff was specified, which is the conventionally ac-
cepted stringency for identification of functional mammalian regula-
tory elements.20 The 5000- to 280-bp genomic sequence of mouse
Opa3 was compared with that of corresponding human, rat, dog, cow,
Macaca, and chimp sequences (5 kb is the approximate distance
between Opa3 and the nearest upstream gene, Grp4, in the mouse).
Mulan’s graphic alignment used the mouse sequence as the reference
sequence. The results were submitted to MultiTF (http://multitf.dcode.
org/ a database allied with pSORT) using the “optimized for function”
search option of MultiTF to identify conserved transcription-factor
consensus sequences. A large number of possible transcriptional fac-
tor–binding sites (TFBSs) were identified. We focused analysis only on
the sequences that are evolutionary conserved upstream of Opa3.
The sequence data from the conserved regions identified by align-
ment with Mulan was entered into commercial software21 (Matin-
spector; Genomatix, Munich, Germany)21 and TFsearch (http://www.
cbrc.jp/research/db/TFSEARCH.html) with a core similarity cutoff value
set at0.9. We also used PreMod Mouse Mar. 2005 assembly (mm6, Build
34; http://genomequebec.mcgill.ca/premod/ McGill University, Montreal,
Quebec, Canada) for genome-wide cis-regulatory module (CRM) predic-
tions. Our selection of programs and high stringencies were chosen to
complement each other for a more robust and accurate prediction of
TFBSs in the 5 region.
RESULTS
Murine Opa3a Is Highly Expressed in Lens and
Retina in Opa3/ Mice
Murine Opa3 consists of three exons. Exon 1 is 181 bp (En-
sembl position Chr7 19,813,753–19,813,933; Ensembl genome
browser, The Sanger Center, Cambridge, UK22) and exon 2 is
398 bp (Ensembl position 19,830,103–19,830,501), with an
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exon 1 to 2 intronic sequence of 16,169 bp. Opa3 exon 3 is
469 bp in mouse (Ensembl position Chr 7 19,840,705–
19,841,173) with an exon 2-3 intronic sequence of 26,771 bp.
Comparison of the mouse exon 3 sequence with mouse exon
2 sequence showed a 61% sequence identity. The murine
transcript a and transcript b sequence that we generated is
given in Figure 1A. Primer pairs spanning exons 1-2 and exons
1-3 yielded products compatible with two predicted splice
variants, transcripts a and b. Transcript a (exon 1-2) and tran-
script b (exon 1-3) were expressed in all six wild-type mouse
tissues tested. Exons 2 and 3 do not splice (Fig. 1B). Murine
Opa3 therefore has two transcripts, both ubiquitously ex-
pressed, similar to findings recently reported in human tis-
sue.10 Quantitative PCR assessment of the relative expression
of all isoforms versus isoform b in wild-type and homozygous
mutant Opa3/ mice at P7 and P30 shows that transcript b is
expressed at less than 10-fold levels in lens and retina and that
the presence of the mutation does not disturb this ratio (Fig.
1C). The two transcripts are predicted to give rise to two
similar peptides, with 61% sequence identity (shown aligned in
Supplementary Fig. S1, http://www.iovs.org/lookup/suppl/
doi:10.1167/iovs.10- 6406/-/DCSupplemental).
Opa3 Is Widely Expressed in Embryonic
Development and Adult Ocular Tissues
Opa3 mRNA was found to be ubiquitous at all time points
studied in mouse embryonic development, from E8 to P0.
Opa3 was present in the lens, retina, and optic nerve of the
adult mouse eye (P30; Fig. 2A). The level of protein expressed
in eight different tissues from wild-type animals was investi-
gated by Western blot analysis (Figs. 2B, 2C). Whole-tissue
lysates from adult animals (equal protein loading by BCA assay;
Thermo Scientific-Pierce) were probed for the presence of
Opa3 with two different antibodies (mouse and rabbit poly-
clonal antibodies). Porin was used as a loading control, show-
ing the relative amount of mitochondria in the tissue lysates,
rather than the amount of tissue loaded. Opa3 was present in
all tissue tested. Under our normal running conditions (Laem-
mli sample buffer containing 100 mM DTT) in lens, Opa3
predominantly stained a band of 20 kDa, as expected, with a
much fainter band at approximately 40 kDa. In retina, the
OPA3 antibody immunostained both bands again, but was
more predominant at 40 kDa than at 20 kDa. In all other
tissues, only the 40-kDa band was detected. This band was
most abundant in retina, brain, and skeletal muscle; moderately
abundant in liver, heart, and kidney; and just detectable in
lung, mirroring the abundance of mitochondria in these tissue
lysates as shown by the presence of VDAC/Porin, a mitochon-
drial outer membrane channel forming protein (Fig. 2B). With
high levels of reducing agent (Laemmli sample buffer contain-
ing 400 mM DTT), 20-kDa bands were apparent in addition to
the 40-kDa band for all mouse tissues tested (Fig. 2C), for a liver
mitochondrial fraction, and for a lysate made from cultured
HEK (human embryonic kidney) 293 cells.
Immunostaining of wax sections using DAB histochemistry
showed that, in the developing eye (E16.5), Opa3 was abun-
dant in the extraocular muscles, anterior epithelial cells of the
lens, the cortical lens fibers, and the retina (Fig. 3). Ganglion
cell axons were particularly densely stained as they grew into
the optic stalk, forming the optic nerve (Fig. 3 inset). In the
adult eye, most layers of the retina demonstrated abundant
Opa3 immunostaining, with the greatest concentration in the
ganglion cells and nerve fiber layer, the inner nuclear layer, and
the layer containing the cell bodies of the rods and cones.
Opa3 immunoreactivity was also moderately abundant in both
the inner and outer plexiform layers and in the inner segments
of the photoreceptor layer (Fig. 4A). Abundant staining was
seen in the extraocular muscles (Fig. 4B). In the cornea, both
epithelial and endothelial cell layers were Opa3 positive (Fig.
4C); however, Opa3 immunoreactivity was absent from the
corneal stroma. In both immature (Fig. 4D) and adult (Fig. 4E)
lenses, Opa3 staining was most abundant in the cuboidal lens
epithelial cells, which cover the anterior portion of the lens,
and in the lens fiber cells lying underneath this epithelium (Fig.
3). Staining was also relatively abundant in the cortical region
of the lens, although it was absent from a band of cortical
secondary fiber cells and was visible in the region where the
organelle-free zone forms (i.e., where mitochondria are ac-
tively being degraded). It was absent from the nuclear fibers
and the organelle-free zone, which develop at the center of the
lens as it matures.
Validation of OPA3 Antibodies
The presence of a higher molecular size band (40 kDa) in
immunoblots of mouse tissue was unanticipated. In all three
different commercially available antibodies were used in an
attempt to validate this result. All three antibodies detected
20-kDa bands in immunoblots of lens and retina tissue, with an
additional approximately 40-kDa band also present in lens and
retina (Fig 2). In all other tissues tested, only the 40-kDa band
was detectable. Staining of both bands in immunoblots (and of
FIGURE 2. Opa3 mRNA is expressed from early development, and the
protein is present in all adult tissues tested. (A) RT-PCR showing
expression of Opa3 during embryonic development in whole embryos
from E8 to E10, in head and body subsets of embryos from E13 to birth,
and in adult (P30) lens, retina, and optic nerve. (B) Western blot of
Opa3 protein expression in a panel of mouse tissue lysates (skeletal
muscle, kidney, heart, liver, lung, brain, retina and lens). In the blot
shown, rabbit anti-Opa3 antibody was used and detects bands at 20
and/or 40 kDa (top). Bottom: VDAC/Porin as a mitochondrial marker.
(C) Western blot of Opa3 protein expressed in human embryonic
kidney cells (HEK) and in a panel of mouse tissue lysates (kidney, liver
mitochondrial fraction, liver, lung, brain, retina, and lens), using in-
creased reducing agent in sample buffer. Rabbit anti-Opa3 antibody
detected bands at 20 and 40 kDa (top). (Composite image from more
than one gel.)
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sections or cells in immunocytochemical or immunohisto-
chemical procedures) was readily abolished by preabsorption
of the antibody with appropriate peptides. In immunofluores-
cence experiments, Opa3 immunostaining was localized to the
mitochondrion in several of the species (Fig. 5), and by West-
ern blot, Opa3 was also detected in the mitochondrial fraction
(Fig. 6). Whole-tissue lysates and mitochondrial-enriched sub-
cellular fractions derived from the corresponding tissue de-
tected bands of the same size (40 kDa), but with a stronger
signal from mitochondrial fractions, as would be expected
with a protein thought to localize within the mitochondrion.
Mutant Opa3/ Localizes to Mitochondria and
Disrupts Mitochondrial Architecture
Opa3 immunostaining was localized to the mitochondria in
mouse embryonic fibroblasts derived from wild-type (Fig. 5A)
or mutant (Fig. 5D) animals. Mitochondrial localization was
verified by counterstaining with a fixable vital dye (Mito-
Tracker Red CMXRos; Invitrogen). Figure 5A shows that most
of the Opa3 signal co-localized with red-stained mitochondria
to produce an orange co-localization signal (the inset shows a
higher magnification of the mitochondria). The pattern of
mitochondrial localization within the cell (Fig. 5B; CMXRos
stain; Invitrogen) can be compared with the pattern of immu-
nostaining obtained with an antibody to OPA3 (Fig. 5C). Lo-
calization of Opa3 immunostaining did not affect the presence
of the mutation in embryonic fibroblasts derived from homozy-
gous mutant animals (Figs. 5D–F). However, co-localization of
Opa3 with the mitochondria is not total in either wild-type or
mutant cells, and although all mitochondria contain Opa3 sig-
nal, not all Opa3 immunostaining appears to be associated with
mitochondrial organelles. This is likely to be due to some
measure of nonspecific staining by the antibody, but could
indicate a distinct subpopulation of Opa3 within the cell,
which is not as yet associated with mitochondrial organelles
and may indicate transport vesicles or protein destined for
import into the mature mitochondrion. However, the mutant
Opa3 protein does not appear to induce any mitochondrial
network fragmentation.
Mitochondria are known to serve a variety of functions,
which may vary in importance depending on cell type. Some
mitochondrial functions are performed only in specific types
of cells—for example, mitochondria in liver cells—detoxify
waste products of protein metabolism. For this reason, we
investigated the distribution of Opa3 in a variety of cell
types. Opa3 immunostaining was present in all cells tested
and localized to the mitochondria. These included Vero
cells, an epithelial cell line derived from monkey kidney
(Fig. 5G), and rat liver Brl cells, a hepatocyte-like, liver-
derived cell line (Fig. 5H). In all cases Opa3 immunostaining
co-localized predominantly with the mitochondria. Mito-
chondria share some roles with the peroxisomes, which are
small organelles with diverse, cell-dependent functions that
are scattered throughout the cell and play a part in the
breakdown of long-chain fatty acids. In addition to these
shared roles, other lines of evidence have hinted at the
possibility that Opa3 has a functional role in the peroxi-
some. The Opa3 protein contains a C-terminal tripeptide
sequence that has been suggested to share similarity with
known peroxisomal targeting sequences.6 Some cell lines,
including Brl (Fig. 5I) and Mef (Fig. 5J) were immunostained
with anti-OPA3 antibody and a peroxisomal-membrane
marker (PMP-70). In all cells, immunostaining was separate,
and there was no evidence of co-localization of Opa3 with
the peroxisome. It therefore appears that Opa3 is an integral
protein of the mitochondrion and that any observed nonmi-
tochondrial staining is not derived from an association with
peroxisomes.
FIGURE 3. Opa3 is present in the developing eye. DAB immunohisto-
chemistry of wax sections from E16.5 mouse embryos (main figure).
Sections immunostained with a rabbit polyclonal antibody to Opa3
labeled with DAB (brown) and counterstained with hematoxylin
(blue). Inset: the developing optic nerve from E14.5 embryo showing
migration of retinal ganglion cell axons into the optic nerve. LE, lens
epithelium; LC, cortical lens fibers; R, retina; OM, extraocular muscle.
Scale bar, 50 m.
FIGURE 4. Opa3 was abundant in the
ocular structures. DAB immunohisto-
chemistry of wax sections showing
the distribution of Opa3 in (A) retina,
(B) extraocular muscle, (C) cornea,
and (D, E) lens. (A) Section of retina
from P7 mouse, immunostained us-
ing an antibody to OPA3 (brown)
and counterstained with hematoxy-
lin (blue). Layers of the retina are
RPE, retinal pigment epithelium; OS,
outer segments; and IS, inner seg-
ments of the photoreceptor layer;
ONL, outer nuclear layer; OPL, outer
plexiform layer; INL, inner nuclear
layer; IPL, inner plexiform layer; and
GC, ganglion cell. Inset: DAB-stained retina without hematoxylin counterstain. (B) Extraocular muscle (M). (C) Cornea, consisting of epithelial layer
(Ep), stroma (S), and endothelial layer (En). (D, E) Lenses from P7 (D) and 9-week-old (E) mice. Blue: nuclei (N). Lens divides into two regions
of outer cortical fibers (LC) and inner nucleus (N). As the lens matures, the innermost lens fibers lose all organelles, forming the organelle-free zone
(OFZ). Opa3 immunostaining with rabbit polyclonal antibody. Scale bars, 50 m.
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The mouse model B6;C3-Opa3L122P, generated by ENU mu-
tagenesis for these studies, has a missense point mutation in
the second exon of the gene, giving rise to the substitution of
a proline residue for leucine at position 122. A variety of
web-based bioinformatics programs were used to predict
changes in protein structure that are likely to arise from this
substitution and indicated a putative change in the surface
accessibility of the protein in this region. Opa3 immunostain-
ing localized to mitochondria in cultured Mef cells derived
from wild-type animals. No change in this distribution was
apparent in animals homozygous for the mutation in Opa3.
Western blot analysis was also used to confirm the mitochon-
drial localization of Opa3 in subcellular fractions of wild-type
and homozygous mutant Mef cells. Equivalent protein concen-
trations were loaded from four subcellular fractions (nuclear,
cytoplasmic, microsomal, and mitochondrial) and were sepa-
rated by reducing SDS-PAGE. Opa3 immunoreactivity was
found only in the band representing the mitochondrial fraction
in both wild-type and mutant cells, and the presence of the
L1223P mutation did not affect distribution of the protein
(Fig. 6A). Opa3 was not detectable in the cytoplasmic or
microsomal fractions, suggesting that if Opa3 protein is pres-
ent in locations other than the mitochondria within the cell, it
is at very low levels.
During development, mitochondrial protein expression was
not grossly affected by the presence of the Opa3 L1223P
mutation (Fig. 6B). Western blot analysis of lysates from E12.5
embryo heads from wild-type or homozygous mutant animals
(Opa3/) were probed with antibodies to the mitochondrial
membrane protein VDAC/Porin, and to the mitochondrial en-
zymes Cox VI and MnSOD. Levels of all of these proteins were
identical when comparing blots from wild-type and homozy-
gous mutant animals at this time point (densitometry data not
shown). Comparison of lysates obtained from embryonic tissue
(E12.5) of mice, with or without the Opa3 L122P mutation by
Western blot analysis, showed that the relative protein mass of
peroxisomes was also unaltered (Fig. 6B). By nonreducing
SDS-PAGE, Opa3 was shown to run at a much higher molecular
weight, suggesting that it may associate with itself or other
proteins to form higher molecular weight complexes in vivo
(Fig. 6C). In nonreducing SDS-PAGE, proteins are denatured
and coated by SDS to allow passage through the gel, but no
reducing agent is added, allowing retention of disulfide bonds
that hold subunits and complexes together. The bands contain-
ing immunoreactive wild-type and mutant Opa3 run at approx-
imately 200 kDa.
Transmission electron microscopy of retinal tissues taken
from adult wild-type and homozygous mutant mice revealed
subtle alterations to the morphology of mitochondrial cristae in
mutants (Fig. 7). Cristae assessed in 21 mitochondria from
homozygous animals appeared to be more dilated than in 40
mitochondria from normal, wild-type littermate controls. Sec-
tions show comparable mitochondria from the inner nuclear
FIGURE 5. Opa3 localized to mitochondria in a variety of cells, but did not colocalize with peroxisomes. Immunostaining with mouse polyclonal
anti-human OPA3 antibody. (A) Merged image of an embryonic fibroblast cell derived from a wild-type mouse, immunostained to show Opa3
(green) with mitochondria labeled in vivo using the mitochondrion probe (red). Inset: a higher-power image of dual-stained mitochondria from
a different image. (B) Mitochondrial (red) staining or (C) Opa3 (green) immunostaining only. (D) Embryonic fibroblast derived from a homozygous
mutant mouse, immunostained as for wild-type (anti-OPA3 green, mitochondrial probe, red). Inset: a higher power image of dual-stained
mitochondria from a different image. (E) Mitochondrial staining (red) or (F) Opa3 (green) immunostaining only. (G) Merged image of Vero cell
(G) and Brl cell (H) immunostained with an antibody against Opa3 (green) and labeled with the mitochondrial probe (red). (I, J) Merged images
of Brl (I) and wild-type Mef (J) cells immunostained with antibodies against OPA3 and a peroxisomal marker, PMP-70, labeled with a 594
nm-conjugated secondary antibody (red). In all preparations except (J), Hoechst 33342 DNA stain was used to counterstain nuclei (blue). Scale
bars: (A, G) 25 m; (D–F), 10 m.
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layer of the retina in wild-type (Figs. 7A–C) or homozygous
(Figs. 7D–F) animals.
Opa3 Protein Accumulates in Ageing Lens
Western blot analysis of lysates from wild-type lenses at birth
(P0), P7, P14, P30, and P90 demonstrated that Opa3 protein is
present at birth and the protein content increased markedly
with age (Fig. 8A). We confirmed that Opa3 was present in the
lens at P0, but at much lower levels than in the adult. This
increase was mirrored by the mitochondrial outer membrane
channel protein VDAC/Porin (Fig. 8A). However, over the
same time frame, levels of the mitochondrial matrix antioxi-
dant enzyme MnSOD remained relatively stable (densitometry
data not shown) raising the possibility that Opa3, and other
membrane proteins such as Porin, accumulate as the lens ages,
possibly as a result of slower breakdown and turnover.23,24
Comparison of Western blots from age-matched wild-type
and homozygous lens lysates (for example, P30; Fig. 8B)
showed that the antioxidant enzyme MnSOD was more highly
expressed in adult homozygous animals, which was not seen in
blots from embryonic tissue. No consistently significant differ-
ence was detectable in the levels of Opa3 in wild-type and
homozygous lens lysates. However, further investigation of the
relative expression of Opa3 mRNA in the lens by real-time
quantitative PCR (Fig. 8C) showed that levels of Opa3 cDNA
were equivalent at P7 in both wild-type and homozygous
lenses, but that Opa3 cDNA was reduced in wild-type P30 lens
(P 	 0.012) but not in homozygous mutant lenses. There was
a statistically significant increase in Opa3 expression in P30
homozygous mutant mice compared with P30 wild-type (P 	
0.019). The same trend was reflected in the levels of MnSOD in
lenses, (Fig. 8D). In week-old (P7) mice, relative levels of
MnSOD cDNA, as measured by qPCR, were not significantly
different in the wild-type and the homozygous animals. By P30
expression of MnSOD had dropped in the wild-type mice (P 	
0.0007) but not in the homozygous mutant animals (Fig. 8D).
There was a statistically significant increase in MnSOD expres-
sion in P30 homozygous mutant mice compared with that in
the P30 wild-type (P 	 0.004). This result suggests that the
presence of the Opa3 mutation places an oxidative burden on
the older lens, to which cells respond by elevating levels of the
mitochondrial antioxidant enzyme.
Putative Transcription Factor Binding Sites
Reflect Phenotypic Features of the
B6;C3-Opa3L122P Mouse
Multispecies Mulan conservation analysis of exon 1 and the
5-kb region upstream of Opa3 revealed three discrete elements
of noncoding evolutionary conserved regions (ECRs) that are
conserved in all seven vertebrate lineages using a100 bp and
70% identity cut off (Fig. 9). These three elements are at
3538 to 3236 bp, 1326 to 1015 bp, and 420 to 143
bp. If even more stringent parameters are imposed (200 bp
and 77% identity) only the 1326 to 1015-bp region is
significantly conserved. Mulan alignment between mouse and
the six other mammalian species showed nine multiconserved
TFBSs in these conserved regions (Fig. 9), all of which except
one (RBP-JK) were clustered in the most conserved region of
1326 to1015 bp. Genomatix Matinspector found six TFBSs
in the conserved regions and TFSEARCH identified 18. PreMod
produced four CRMs: two upstream and two downstream of
Opa3. The two CRMs upstream of Opa3 predicted 29 TFBSs. In
total, using several databases, we identified 53 putative TFBSs
in the mouse Opa3 5-kb upstream region, and these conse-
quently suggest many putative regulatory proteins that could
potentially modulate Opa3 expression (Supplementary Table S1,
http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.10-6406/-/
DCSupplemental, and Table 1).
DISCUSSION
Murine Opa3 gives rise to two splice variants, Opa3a and
Opa3b, which are expressed in a wide range of adult mouse
tissues and throughout embryonic development. Expression of
Opa3b (exon 1-3) was at least a tenth of total Opa3 transcript
expression, in both lens and retina. Our findings therefore
agree with results obtained in humans.10 There are two pre-
dicted peptides in mice; however, it has not proved possible to
speculate as to the functional significance of these two tran-
scripts, as the Opa3 protein has no known homologies, and
therefore bioinformatic tools do not currently provide any
meaningful functional predictions. Opa3 was ubiquitously ex-
pressed at all time points from E8 to P30 and in all tissues
studied, including brain, skeletal muscle, and eye. Of signifi-
cance to the neuro-ophthalmic features of the disease MGA
type III (Costeff) syndrome and to the ADOA and cataract
phenotype, Opa3 was expressed in the developing lens and
retina and in other ocular structures, such as the extraocular
muscles and cornea. Opa3 expression was high in the devel-
oping retinal ganglion cells of the optic nerve at E14.5. Intro-
duction of a point mutation into the second exon of Opa3 in
FIGURE 6. Presence of the Opa3 mutation does not affect its subcel-
lular location, the expression of a panel of mitochondrial proteins or
formation of high-molecular-weight complexes. (A) Western blot anal-
ysis of subcellular fractions derived from cultured Mef cells. Cells from
wild-type or homozygous animals were fractioned with a mitochon-
drial isolation kit. Equal protein loadings from the cytosolic (cyto)
mitochondrial (mito), and microsomal (micro) fractions were sepa-
rated by SDS-PAGE and immunoblotted, using antibodies against Opa3
(mouse polyclonal in the blot shown). (B) Western blot of lysates from
whole embryonic tissue (E12.5) derived from wild-type (/),
heterozygous (/), or homozygous animals (/). Blots were
probed using a panel of mitochondrial antibodies: Opa3 (rabbit poly-
clonal in the blot shown), Cox VI, MnSOD, and Porin; a peroxisomal
marker, PMP-70, and -actin as a loading control. (C) Nonreducing gel
of lysates from wild-type or homozygous embryonic tissue (E12.5)
immunoblotted using antibodies to OPA3 (rabbit polyclonal in the blot
shown), with -actin as a loading control.
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the B6;C3-Opa3L122P mouse gave rise to a phenotype that
mimics human recessive MGA type III (Costeff) syndrome.
However, the presence of the missense mutation did not alter
the relative high expression of Opa3a versus Opa3b transcripts
in lens and retina.
To further explore the subcellular localization of Opa3 and
the effects of its mutation, we used immunostaining and im-
munoblot techniques. In this study, three commercially avail-
able antibodies to human OPA3 were tested for their ability to
recognize mouse opa3 in several different tissues and using a
variety of techniques. These were (1) a mouse polyclonal
raised against full-length human OPA3, (2) a rabbit anti-human
OPA3 polyclonal antibody raised against a partial peptide se-
quence from amino acid 24-179, and (3) a goat polyclonal
antibody raised against an internal epitope of human OPA3.
Two of the antibodies were tested for immunostaining of cells
and wax sections: The mouse polyclonal antibody was used for
immunofluorescence studies, and gave good results in metha-
nol or acetone-methanol fixed cultured cells of mouse, rat, and
monkey origin (Fig. 5). Immunohistochemical staining of wax
sections using DAB histochemistry could only be achieved
with the rabbit polyclonal antibody (Figs. 3, 4). By Western
blot, all three antibodies detected bands at approximately 20
kDa (the predicted size of the protein) in mouse lens, retina,
and all other tissues studied and also at 40 kDa in various
intensities in all tissues. The protein product of the Opa3 gene
is very similar in human and mouse, particularly in the N-ter-
minal half of the protein, with 84% to 86% conserved identity
of amino-acid residues in peptide sequences used to raise two
of the antibodies tested. Immunostaining (of blots and cells)
was abolished when antibodies were preincubated with the
appropriate immunizing peptides.
In addition to validation by each manufacturer, the rabbit
polyclonal antibody has been independently validated by Owc-
zarek-Lipska et al.,25 who successfully detected OPA3 in immu-
noblots of a human 293T cell line transfected with the bovine
protein and in isolated bovine heart mitochondria, although
the authors did not report the presence of any higher molec-
ular weight bands. In this study we observed that three differ-
ent antibodies, raised in different species and to slightly differ-
ent regions of human OPA3 all give similar results in Western
blots of mouse tissue.
The presence of an additional, larger band by Western blot
of mouse tissue might arise if the antibody recognizes alterna-
tive splice variants. It has been demonstrated that Opa3 has at
least two splice variants in human,10 bovine,25 and now in this
study, in mouse, which arise by the splicing of exon 1-2 and 1-3,
producing transcript 1 -2 and transcript 1-3. However, the splice
variants reported to date differ by only a fewpeptides (61% sequence
identity; Supplementary Fig. S1, http://www.iovs.org/lookup/
suppl/doi:10.1167/iovs.10-6406/-/DCSupplemental) and would not
produce proteins of significantly different sizes. Intriguingly, an early
study of Opa3,6 in which Northern blot analysis of total RNA was
used, demonstrated the presence of twobands, at 5 and 8 kb, which
hybridized to the human OPA3 probe and which might there-
fore suggest the presence of a further transcript. Alternatively,
various posttranslational modifications might significantly alter
the size of the protein and its running characteristics by SDS-
PAGE, and this could be differentially regulated. Finally, the
protein could form part of a multimeric complex that may not
necessarily be completely dissociated by SDS-PAGE. For exam-
ple, some single-pass transmembrane proteins, such as glyco-
phorin A, can form SDS-resistant dimmers due to the distribu-
tion of charge on the protein, such that regions of protein–
protein interaction are internalized and protected from
denaturation by SDS. Interestingly, it has been speculated13
that Opa3 might be such a single-pass membrane protein. In
this study, we shifted Opa3 immunostaining from a single,
40-kDa band seen in most of the mouse tissues, to a combina-
tion of 20- and 40-kDa bands by the addition of increased
FIGURE 7. Presence of the Opa3 mutation alters mitochondrial morphology. Representative transmission electron micrographs of mitochondria
from retinas of adult wild-type (A–C) and homozygous mutant (D–F) littermate mice, showing that mitochondrial cristae are more disorganized
and fragmented in homozygous mutant retina. Scale bar, 1 m.
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amounts of the reducing agent DTT to our sample buffer. We
therefore speculate that the 20- and 40-kDa bands are both
correctly recognized as Opa3 and that the 40-kDa form is a
multimeric form of Opa3—possibly a dimer—that requires
strongly reducing conditions, to be pried apart.
Wild-type, native Opa3 is localized to mitochondria across a
variety of cell types by immunostaining and has also been
shown to have mitochondrial localization by subcellular frac-
tionation experiments. We have demonstrated that despite the
presence of a putative peroxisomal localization sequence at
the C terminus,6,10 Opa3 does not localize to the peroxisome
in any of the cell types tested. Opa3 therefore functions solely
within the mitochondrion. The mitochondrial location of Opa3
was not disrupted by the presence of mutant protein in em-
bryonic fibroblast cells derived from the B6;C3-Opa3L122P
mouse. No fragmentation of mitochondrial networks was ob-
served in cells from mutant animals, with mitochondria being
similar in appearance to those observed in cells derived from
wild-type animals. However, electron microscopy of the inter-
nal architecture of mitochondria from the retina of mutant
mice indicated subtle alterations to cristae morphology.
The presence of the p.L122P mutation does not appear to
affect the ability of Opa3 to form multimeric complexes, and
Opa3 protein was detected at the same size and in the same
quantity in homogenates from embryonic wild-type and mu-
tant tissue. Therefore, the disease traits displayed in animals
carrying the Opa3 mutation would not appear to be the result
of changes to the protein structure leading to disruption of
interactions between Opa3 and itself, or other downstream
binding partners.
In this study, we have shown that native Opa3 protein
concentration increases during maturation and ageing of the
lens. The amplification of levels of Opa3 protein is greatest
during the first 2 weeks after birth in mice, but continues to
increase thereafter. We have shown that in wild-type animals,
mRNA production decreases over the first month in lens, as
would be expected, since the lens is forming fibers and the
cells are losing their subcellular organelles. Thus, the increased
levels of Opa3 must be due to accumulation of the protein,
perhaps as cellular processes slow. As development pro-
gresses, expression of Opa3 in wild-type and mutant animals
appears to be differentially expressed in an age-related manner.
By Western blot of lysates from E12.5 embryo heads, levels of
Opa3 protein were identical in wild-type and mutant animals,
as were the other mitochondrial proteins investigated. Relative
expression of Opa3 in the lens by qRT-PCR was also equivalent
in wild-type or mutant week-old animals. However, this normal
age-related decrease in Opa3 mRNA expression was not seen in
FIGURE 8. Opa3 protein content in-
creased as the lenses aged. (A) Repre-
sentative Western blot of lysates from
aging wild-type lenses. The blots were
probed with antibodies against Opa3
(mouse polyclonal in the blot shown)
and antibodies against two known mi-
tochondrial markers, VDAC/Porin and
MnSOD, with -actin as a loading con-
trol. Chart shows densitometry analy-
sis of this immunoblot, normalizing
Opa3 and Porin content to the -actin
control (B) Cell lysates from wild-type
(/) or homozygous (/) lenses
aged 30 days and expression levels of
Opa3 protein determined by immuno-
blotting (mouse polyclonal in the blot
shown). Blots were also probed with
antibodies against a panel of mitochon-
drial proteins (Cox IV, VDAC/Porin,
MnSOD) and with -actin as a loading
control. (C, D) qPCR showing relative
expression of Opa3 andMnSOD cDNA
in lenses from wild-type or homozy-
gous animals at postnatal days 7 and
30. *P  0.05, **P  0.005.
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animals carrying the pL122P mutation, suggesting that Opa3
mRNA is upregulated due to the presence of the mutation. The
increase in Opa3 content in mutant animals compared with
wild-type littermate controls has been difficult to prove un-
equivocally by Western blot in lens, which may be due to
accumulation and slow turnover of the protein in this tissue.
Intriguingly, the mitochondrial enzyme MnSOD, which pro-
tects against oxidative damage, is similarly affected by the
presence of Opa3 mutation in lens tissue. We have found that
expression of MnSOD mRNA and protein are elevated in lenses
of older (but are identical in young) animals carrying the
mutation. We speculate that this may be a defense mechanism
to protect the organism against elevated ROS production as
mitochondria age. Why this might occur in the lens is not
known.
Cataract is only reported in ADOA and cataract (ADOAC),
caused by two dominant missense mutations reported in hu-
man OPA3. Recessive type III MGA is not associated with
cataract. The mouse model reported here has a recessive phe-
notype and has many of the features of type III MGA. It is not
FIGURE 9. Mulan alignment revealed
evolutionarily conserved regions up-
stream of Opa3 exon 1. Murine Opa3
sequence was selected as the refer-
ence species; the horizontal axis dis-
plays the input sequence. Evolution-
arily conserved regions were defined
as having70% identity,100 bp. Re-
gions of conserved sequence common
to all six species are indicated by color
density (the darker the color the more
species contain the conserved region).
TABLE 1. Common Functional Themes in the TFBSs Found Upstream of Opa3 and Which TFBSs Are
Known to Play a Role in These Processes
TFBS Neuronal/Retinal
Cellular Stress
Response/Apoptosis Craniofacial/Bone Adipogenesis
P53 and P53 decamer    
CRE-BP    
AP2F    
CREB    
Stat   
Oct-01  
Pax2   
AML-1a  
Chx10  
RBPJK  
Gata3  
Fox01   
E2F1   
Fox04  
C-EBP ab  
NRF 2  
MZF1 
VDR  
OLF1  
SP1  
Pax3  
ATF(inc 3,4,6) 
Cart1 
HFH8 
Gata2 
GR 
TFBS were omitted when no evidence was found of their involvement in any of the functional themes
listed.
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a model for ADOAC and does not display cataract. We do not
know why humans with type III MGA do not get cataract. It has
been suggested that the mutations that which give rise to
ADOAC are positioned in key domains of the native protein
and disrupt specific cellular functions of Opa3 that lead to the
development of cataract. The mutations giving rise to type III
MGA are splice site in-frame deletions and nonsense mutations.
We see relative increase in Opa3 protein and cDNA/ RNA, but
no cataract. This upregulation may be a physiological response
to loss or reduction of function.
Since so little is known about the Opa3 protein, we used a
suite of bioinformatic tools to cast further light on other pos-
sible aspects of Opa3 function and to compare the 5-kb up-
stream proximal sequence of the mouse Opa3 gene with
other homologous mammalian sequences and identify con-
served TFBSs. These TFBSs cluster into functional categories
related to retinal development, cellular stress response,
craniofacial development, and adipogenesis (Table 1.). Some the
predicted TFBSs upstream of Opa3 (Supplementary Table S1,
http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.10-6406/-/
DCSupplemental) are expressed in the retina. Some of those
identified herein are involved in apoptotic responses to DNA
damage. This association may be of significance, since Reynier
et al.4 (and others) have reported that human fibroblasts car-
rying the OPA3 c.227GA (G93S) mutation were more sus-
ceptible to apoptosis induced by staurosporine than were their
wild-type counterparts. Opa3 homozygous mutant mice have
reduced visual acuity and display a significant loss of cells from
the retinal ganglion cell/nerve fiber layer and inner nuclear
layer. Another cluster of TFBSs identified in this study is in-
volved in bone and craniofacial development. This may have
significance, since B6;C3-opa3L122P homozygous mice are
smaller than their wild-type littermates, even during embryo-
genesis, and they show dysmorphic craniofacial features and a
misalignment of the jaw (Votruba, unpublished data, 2011).
Last, some of the predicted TFBSs are involved in adipogenesis.
MRI scans and necropsy of Opa3 homozygous mutant mice
show a significant lack of visceral adipose tissue. Thus, the
disease-related TFBS clusters identified here mirror major phe-
notypic features seen in the B6;C3-Opa3L122P mouse. Identifi-
cation of such TFBS may provide important future insight into
factors, which may regulate Opa3 gene transcription, elucidat-
ing its transcriptional rules and providing important further
clues to the function of the Opa3 protein.
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